BridgeMD
New treatment option for IVF Patients
Official title Endometrial Immune Profile Changes After Autologous Intrauterine PRP Treatment
ClinicalTrials.gov ID: NCT07535190
What this study is testing
What is Platelet rich plasma (PRP)?
Platelet rich plasma (PRP) is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for ivf patients.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The success rate after treatment by in-vitro fertilisation (IVF) strongly depends on the endometrial receptivity, which in turn is strictly connected to the endometrial immune profile. IVF outcome is largely dependent upon endometrial immune cell ratios and their relationship with one another.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- Participating in Assisted Reproduction Treatment
- Having infertility
- Having regular menstrual cycles
- Embryo transfer of euploid embryos
You likely can't join if
- Uterine pathologies
- Endometrial Bacterial infections
- Active endometrial inflammation
- Polycystic ovary syndrome
- Cancer diagnostics
- Positive HIV, HCV or HBV tests
See the full eligibility criteria
- Participating in Assisted Reproduction Treatment
- Having infertility
- Having regular menstrual cycles
- Embryo transfer of euploid embryos
- Uterine pathologies
- Endometrial Bacterial infections
- Active endometrial inflammation
- Polycystic ovary syndrome
- Cancer diagnostics
- Positive HIV, HCV or HBV tests
- Autoimmune diseases
- Recent immune therapy
The study team makes the final eligibility decision.
Where it's taking place
- Sofia, Sofia, Bulgaria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sofia, Sofia, Bulgaria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.